FDA un­ex­pect­ed­ly de­lays roxa de­ci­sion, foil­ing Fi­bro­Gen's Feb­ru­ary roll­out plans

Months af­ter an­a­lysts pre­dict­ed Fi­bro­Gen had an ap­proval in the bag for its chron­ic kid­ney dis­ease-re­lat­ed ane­mia drug rox­adu­s­tat, the FDA has ex­tend­ed its re­view …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER